loadpatents
name:-0.063163995742798
name:-0.02905011177063
name:-0.012709140777588
Piotrowski; David W. Patent Filings

Piotrowski; David W.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Piotrowski; David W..The latest application filed is for "glp-1 receptor agonists and uses thereof".

Company Profile
12.28.51
  • Piotrowski; David W. - Waterford CT
  • Piotrowski; David W. - Groton CT
  • Piotrowski; David W. - Portage MI
  • Piotrowski, David W. - Groton Long Pointe CT
  • Piotrowski, David W. - Groton Long Point CT
  • Piotrowski; David W. - Bear DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
GLP-1 Receptor Agonists and Uses Thereof
App 20210332034 - Aspnes; Gary Erik ;   et al.
2021-10-28
GLP-1 Receptor Agonists and Uses Thereof
App 20210163455 - Aspnes; Gary Erik ;   et al.
2021-06-03
GLP-1 receptor agonists and uses thereof
Grant 10,934,279 - Aspnes , et al. March 2, 2
2021-03-02
Glp-1 Receptor Agonists And Uses Thereof
App 20210047298 - Aspnes; Gary Erik ;   et al.
2021-02-18
GLP-1 receptor agonists and uses thereof
Grant 10,851,081 - Aspnes , et al. December 1, 2
2020-12-01
Glp-1 Receptor Agonists And Uses Thereof
App 20200255406 - Kind Code
2020-08-13
GLP-1 receptor agonists and uses thereof
Grant 10,683,281 - Aspnes , et al.
2020-06-16
GLP-1 receptor agonists and uses thereof
Grant 10,676,465 - Aspnes , et al.
2020-06-09
GLP-1 receptor agonists and uses thereof
Grant 10,669,259 - Aspnes , et al.
2020-06-02
GLP-1 Receptor Agonists and Uses Thereof
App 20190382387 - Aspnes; Gary Erik ;   et al.
2019-12-19
GLP-1 Receptor Agonists and Uses Thereof
App 20190382388 - Aspnes; Gary Erik ;   et al.
2019-12-19
GLP-1 Receptor Agonists and Uses Thereof
App 20190382384 - Aspnes; Gary Erik ;   et al.
2019-12-19
GLP-1 Receptor Agonists and Uses Thereof
App 20190119255 - Aspnes; Gary Erik ;   et al.
2019-04-25
GLP-1 receptor agonists and uses thereof
Grant 10,208,019 - Aspnes , et al. Feb
2019-02-19
GLP-1 Agonists and Uses Thereof
App 20180170908 - Aspnes; Gary Erik ;   et al.
2018-06-21
Substituted Amide Compounds
App 20160058768 - Darout; Etzer ;   et al.
2016-03-03
Substituted amide compounds
Grant 9,227,956 - Darout , et al. January 5, 2
2016-01-05
Substituted Amide Compounds
App 20140315928 - Darout; Etzer ;   et al.
2014-10-23
Morpholine Compounds
App 20110281854 - Casimiro-Garcia; Agustin ;   et al.
2011-11-17
Substituted 3-amino-pyrrolidino-4-lactams
Grant 7,485,641 - Piotrowski , et al. February 3, 2
2009-02-03
(2S,4S)-4-(piperazin-1-yl)pyrrolidine-2-methanone derivatives
Grant 7,465,732 - Hulin , et al. December 16, 2
2008-12-16
Substituted 3-Amino-Pyrrolidino-4-Lactams
App 20070299076 - Piotrowski; David W. ;   et al.
2007-12-27
Therapeutic compounds
Grant 7,291,618 - Hulin , et al. November 6, 2
2007-11-06
Therapeutic Compounds
App 20070161664 - Hulin; Bernard ;   et al.
2007-07-12
Therapeutic compounds
App 20070099897 - Hulin; Bernard ;   et al.
2007-05-03
1H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment of disease
Grant 7,176,198 - Piotrowski , et al. February 13, 2
2007-02-13
Methods of modulating the activities of alpha-7 nicotinic acetylcholine receptor
App 20060142349 - Hurst; Raymond S. ;   et al.
2006-06-29
Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease
Grant 7,067,515 - Wishka , et al. June 27, 2
2006-06-27
1H-pyrazole and 1h-pyrole-azabicyclic compounds for the treatment of disease
App 20060116395 - Piotrowski; David W. ;   et al.
2006-06-01
Therapeutic compounds
App 20060079498 - Hulin; Bernard ;   et al.
2006-04-13
Azabicyclic compounds for the treatment of disease
Grant 7,001,900 - Jacobsen , et al. February 21, 2
2006-02-21
Therapeutic compounds
App 20050256310 - Hulin, Bernard ;   et al.
2005-11-17
Positive allosteric modulators of the nicotinic acetylcholine receptor
App 20050250816 - Piotrowski, David W. ;   et al.
2005-11-10
Azabicyclic-substituted fused heteroaryl compounds for the treatment of disease
App 20050234092 - Walker, Daniel Patrick ;   et al.
2005-10-20
Dipeptidyl peptidase-IV inhibitors
App 20050234065 - Hulin, Bernard ;   et al.
2005-10-20
Azabicyclic-substituted fused heteroaryl compounds for the treatment of disease
App 20050222196 - Walker, Daniel Patrick ;   et al.
2005-10-06
Azabicyclic-phenyl-fused-heterocyclic compounds for treatment of disease
Grant 6,951,868 - Walker , et al. October 4, 2
2005-10-04
Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatment of disease
App 20050215584 - Rogers, Bruce N. ;   et al.
2005-09-29
Azabicyclic-substituted-heteroaryl compounds for the treatment of disease
Grant 6,919,359 - Piotrowski , et al. July 19, 2
2005-07-19
Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
Grant 6,911,543 - Walker , et al. June 28, 2
2005-06-28
Treatment of attention defecit hyperactivity disorder
App 20050107425 - Rogers, Bruce N. ;   et al.
2005-05-19
Azabicyclic compounds for the treatment of disease
Grant 6,894,042 - Walker , et al. May 17, 2
2005-05-17
Substituted azabicyclic moieties for the treatment of disease
Grant 6,869,946 - Jacobsen , et al. March 22, 2
2005-03-22
Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatment of disease
Grant 6,858,613 - Rogers , et al. February 22, 2
2005-02-22
Substituted-aryl compounds for treatment of disease
Grant 6,852,716 - Walker , et al. February 8, 2
2005-02-08
N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease
Grant 6,849,620 - Walker , et al. February 1, 2
2005-02-01
Positive allosteric modulators of the nicotinic acetylcholine receptor
App 20040254373 - Piotrowski, David W. ;   et al.
2004-12-16
Positive allosteric modulators of the nicotinic acetylcholine receptor
App 20040249150 - Piotrowski, David W. ;   et al.
2004-12-09
Quinuclidine-substituted hetero-bicyclic aromatic compounds for the treatment of disease
Grant 6,828,330 - Walker , et al. December 7, 2
2004-12-07
Azabicyclic compounds for the treatment of disease
App 20040224976 - Walker, Daniel Patrick ;   et al.
2004-11-11
Quinuclidine-substituted hetero-bicyclic aromatic compounds for the treatment of disease
App 20040224977 - Walker, Daniel Patrick ;   et al.
2004-11-11
Compounds as radioligands for the diagnosis of disease
App 20040157878 - Rogers, Bruce Nelson ;   et al.
2004-08-12
Compounds having both alpha7 nicotinic agonist activity and 5HT3 antagonist activity for the treatment of CNS diseases
App 20040147522 - Wong, Erik Ho Fong ;   et al.
2004-07-29
1H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment of disease
App 20040087616 - Piotrowski, David W. ;   et al.
2004-05-06
Substituted-aryl compounds for treatment of disease
App 20030236279 - Walker, Daniel Patrick ;   et al.
2003-12-25
Azabicyclic compounds for the treatment of disease
App 20030236270 - Jacobsen, Eric Jon ;   et al.
2003-12-25
Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatment of disease
App 20030236264 - Rogers, Bruce N. ;   et al.
2003-12-25
Positive allosteric modulators of the nicotinic acetylcholine receptor
App 20030236287 - Piotrowski, David W. ;   et al.
2003-12-25
Azabicyclic compounds for the treatment of disease
App 20030232853 - Walker, Daniel Patrick ;   et al.
2003-12-18
Azabicyclic-substituted-heteroaryl compounds for the treatment of disease
App 20030207913 - Piotrowski, David W. ;   et al.
2003-11-06
N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease
App 20030176702 - Walker, Daniel Patrick ;   et al.
2003-09-18
Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
App 20030153595 - Walker, Daniel Patrick ;   et al.
2003-08-14
Quinuclidine-substituted heteroaryl moieties for treatment of disease
Grant 6,599,916 - Myers , et al. July 29, 2
2003-07-29
Azabicyclic-phenyl-fused-heterocyclic compounds for treatment of disease
App 20030130305 - Walker, Daniel Patrick ;   et al.
2003-07-10
Quinuclidine-substituted hetero-bicyclic aromatic compounds for the treatment of disease
App 20030073707 - Walker, Daniel Patrick ;   et al.
2003-04-17
Substituted-heteroaryl-7-aza[2.2.1] Bycycloheptanes For The Treatment Of Desease
App 20030069290 - Wishka, Donn G. ;   et al.
2003-04-10
Substituted azabicyclic moieties for the treatment of disease
App 20030055043 - Jacobsen, Eric Jon ;   et al.
2003-03-20
Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease
App 20030045540 - Wishka, Donn G. ;   et al.
2003-03-06
Quinuclidine-substituted heteroaryl moieties for treatment of disease
Grant 6,500,840 - Myers , et al. December 31, 2
2002-12-31
Quinuclidine-substituted aryl compounds for treatment of disease
Grant 6,492,386 - Myers , et al. December 10, 2
2002-12-10
Quinuclidine-substituted aryl compounds for treatment of disease
Grant 6,486,172 - Myers , et al. November 26, 2
2002-11-26
Quinuclidine-substituted aryl compounds for treatment of disease
Grant 6,479,510 - Myers , et al. November 12, 2
2002-11-12
Quinuclidine-substituted heteroaryl moieties for treatment of disease
App 20020091135 - Myers, Jason K. ;   et al.
2002-07-11
Quinuclidine-substituted aryl compounds for treatment of disease
App 20020052389 - Myers, Jason K. ;   et al.
2002-05-02
Quinuclidine-substituted aryl compounds for treatment of disease
App 20020049225 - Myers, Jason K. ;   et al.
2002-04-25
Quinuclidine-substituted heteroaryl moieties for treatment of disease
App 20020042428 - Myers, Jason K. ;   et al.
2002-04-11
Quinuclidine-substituted heteroaryl moieties for treatment of disease
App 20020042429 - Myers, Jason K. ;   et al.
2002-04-11
Quinuclidine-substituted aryl compounds for treatment of disease
App 20020040035 - Myers, Jason K. ;   et al.
2002-04-04
Arthropodicidal anilides
Grant 5,602,126 - Barnette , et al. February 11, 1
1997-02-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed